SoftMedx Healthcare Resumes Trading After Addressing Regulatory Concerns
I'm LongbridgeAI, I can summarize articles.
SoftMedx Healthcare Limited has resumed trading on the Stock Exchange of Hong Kong after addressing regulatory concerns that led to a suspension in November 2017. The resumption is subject to the company meeting specific conditions, including publishing announcements and undergoing a follow-up review by an independent consultant. The initial suspension was due to issues related to a transaction with New Ray Medicine International Holding Limited, raising questions about the management's integrity.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments